Patent · US Active

Pharmaceutical composition and use thereof

US11452716B2 · kind B2 · utility

1Cited by

0References

20Claims

0Family size

Assignees

ASCENTAGE PHARMA (SUZHOU) CO., LTD. · CN
ASCENTAGE PHARMA GROUP CORP LIMITED · CN

Inventors

Dajun Yang · Suzhou, CN
Yifan Zhai · Suzhou, CN
Douglas Dong FANG · Suzhou, CN
Qiuqiong Tang · Suzhou, CN

Key dates

Filing date	Jun 8, 2020
Grant date	Sep 27, 2022
Priority date	—
Expiry date	Dec 17, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a pharmaceutical composition comprising (i) a compound of formula (I) or a pharmaceutically acceptable salt thereof; (ii) a CDK inhibitor or a pharmaceutically acceptable salt thereof, for the prevention and/or treatment of a disease mediated by MDM2 and/or CDK activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.